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mTORC1 controls key processes that regulate cell
growth, including mRNA translation, ribosome bio-
genesis, and autophagy. Environmental amino acids
activate mTORC1 by promoting its recruitment to
thecytosolic surfaceof the lysosome,where its kinase
is activated downstream of growth factor signaling.
mTORC1 is brought to the lysosome by the Rag
GTPases, which are tethered to the lysosomal mem-
brane by Ragulator, a lysosome-bound scaffold.
Here, we identify c17orf59 as a Ragulator-interacting
protein that regulates mTORC1 activity through its
interaction with Ragulator at the lysosome. The bind-
ing of c17orf59 to Ragulator prevents Ragulator
interaction with the Rag GTPases, both in cells and
in vitro, and decreases Rag GTPase lysosomal locali-
zation. Disruption of the Rag-Ragulator interaction by
c17orf59 impairs mTORC1 activation by amino acids
by preventing mTOR from reaching the lysosome.
By disrupting the Rag-Ragulator interaction to inhibit
mTORC1, c17orf59expressionmay representanother
mechanism tomodulatenutrient sensingbymTORC1.
INTRODUCTION
The mechanistic target of rapamycin complex 1 (mTORC1) bal-
ances the metabolic state of the cell with environmental condi-
tions. mTORC1 positively regulates anabolic processes to pro-
mote growth, and it also controls the availability of the building
blocks required for these processes by controlling catabolic
pathways. The anabolic processes regulated by mTORC1
include mRNA translation, ribosomal biogenesis, and lipid and
nucleotide biosynthesis. Autophagy and proteasomal degrada-
tion are the major catabolic degradation pathways influenced
my mTORC1 activity (Laplante and Sabatini, 2012; Zhang
et al., 2014).
BecausemTORC1 activity promotes growth processes, which
are energy intensive and vital for cell division and the functions of
terminally differentiated cells, several aspects of cellular healthCell Recontrol mTORC1 activation. Intracellular conditions, including
low energy levels, DNA damage, and other stress signals, regu-
late mTORC1, in addition to the environmental milieu. Environ-
mental cues that control mTORC1 activity represent the general
nutritional status of the cell or organism so that mTORC1 is acti-
vated by growth factors and nutrients, including amino acids and
glucose, and is inhibited under hypoxia (Zoncu et al., 2011; Shi-
mobayashi and Hall, 2014; Jewell and Guan, 2013; Gomes and
Blenis, 2015; Zhang et al., 2014).
The mTORC1 pathway integrates different environmental sig-
nals by distinct mechanisms, well exemplified by the contrast in
pathway activation by growth factors as compared to nutrients.
Growth factors activate mTORC1 downstream of canonical
phosphatidyl inositol-3-kinase (PI3K)/Akt signaling. Growth-fac-
tor-stimulated Akt activates the small GTPase Rheb by inhibiting
its GTPase activating protein (GAP), tuberous sclerosis complex
(TSC). GTP-bound Rheb activates the mTOR kinase activity (Tee
et al., 2003; Inoki et al., 2002, 2003; Garami et al., 2003; Long
et al., 2005a; Manning et al., 2002; Zhang et al., 2003). However,
in order for Rheb to control the kinase activity of mTORC1, it
must interact with the mTORC1 complex. This interaction is
regulated independently of TSC/Rheb activity and is controlled
by intracellular amino acid and glucose availability (Sancak
et al., 2008, 2010; Efeyan et al., 2013; Long et al., 2005b; Kim
et al., 2008; Smith et al., 2005; Hara et al., 1998; Lynch et al.,
2000; Nobukuni et al., 2005). Specifically, Rheb resides at the
cytosolic face of late endosomal and lysosomal membranes
(Menon et al., 2014), and mTORC1 localizes to these organelles
in an amino-acid- and glucose-dependent manner in order to be
activated.
The Rag GTPases regulate mTORC1 localization and recruit-
ment to lysosomes in response to intracellular nutrient availabil-
ity (Sancak et al., 2008, 2010; Kim et al., 2008). The Rags are
small GTPases encoded by four separate genes (RRAGA, -B,
-C, and -D; coding for RagA, -B, -C, and -D), which form hetero-
dimers in which a single RagA or RagB protein is paired with a
single RagC or RagD. The Rags localize to the cytoplasmic sur-
face of the lysosomal membrane (Sancak et al., 2008, 2010).
Evidence suggests that the nucleotide-bound state of each
Rag protein in the dimer tends to be opposite that of its partner
(Sancak et al., 2008). In the absence of amino acids, the RagA/B
component of the dimer binds GDP and the RagC/D componentports 12, 1445–1455, September 1, 2015 ª2015 The Authors 1445
binds GTP, and the dimer does not bind mTORC1 and therefore
cannot recruit it to the lysosome. Within minutes of the addition
of amino acids to the media of starved cells, the nucleotide-
bound state is reversed such that RagA/B is GTP bound and
RagC/D is GDP bound, leading to the binding and lysosomal
recruitment of mTORC1. Expression of ‘‘active’’ Rag dimer mu-
tants where RagA or RagB mimics the GTP-bound state (RagA/
BGTP) is sufficient to constitutively localize mTORC1 to the lyso-
somal membrane and activate mTORC1, even in the absence of
amino acids. Conversely, mTORC1 activity is inhibited by ‘‘inac-
tive’’ Rag mutant dimers consisting of RagA/BGDP, even when
amino acids are present (Sancak et al., 2008; Kim et al., 2008).
The Ragulator complex maintains the Rags on the lysosome,
and serves as a lysosomal docking site for the Rag dimers.
Five proteins make up Ragulator: p18, p14, MP1, HBXIP, and
c7orf59 (Wunderlich et al., 2001; Nada et al., 2009; Sancak
et al., 2010; Bar-Peled et al., 2012). The complete Ragulator
complex is required for mTORC1 activation by amino acids
and for the appropriate lysosomal localization of the Rags and
mTORC1. Loss of any component of Ragulator inhibits mTORC1
activation by amino acids and mislocalizes both the Rags and
mTORC1 away from the lysosomes, even when amino acids
are present (Sancak et al., 2010; Bar-Peled et al., 2012). Ragula-
tor fulfills two major functions in mTORC1 activation: it acts as a
scaffold and landing pad for the Rags and mTORC1 at the lyso-
some, and it serves as the guanine nucleotide exchange factor
(GEF) for RagA and RagB, activating the mTORC1 pathway in
response to amino acids (Bar-Peled et al., 2012).
In recent years, we have searched for novel regulators of the
mTORC1 pathway, specifically of the amino-acid-sensing arm.
Here, we describe the identification of c17orf59 as a Ragula-
tor-interacting protein and its role in the regulation of mTORC1
activation. c17orf59 binds to Ragulator, but not the Rags, and
inhibits the Rag-Ragulator interaction and mTORC1 activity
when overexpressed. We find that c17orf59 is a component
the pathway that regulates the nutrient-sensing arm of mTORC1
and represents an alternative mechanism to inhibit mTORC1 via
disruption of the interaction between the Rag GTPases and
Ragulator.
RESULTS
c17orf59 Interacts with Ragulator, but Not the Rag
GTPases
In order to identify proteins that may play a role in the amino-
acid-sensing pathway upstream of mTORC1, we used immuno-
precipitation of epitope-tagged Ragulator components followed
by mass spectrometry (IP/MS). Immunoprecipitation of the
FLAG-tagged, stably-expressed Ragulator subunit HBXIP spe-
cifically yielded peptides corresponding to c17orf59 in addition
to the Rag GTPases and other known members of Ragulator
complex (Figure 1A). Consistent with this finding, mass spec-
trometric analysis of immunoprecipitates of stably expressed,
epitope-tagged c17orf59 contained peptides corresponding to
all Ragulator subunits, including p18, p14, MP1, HBXIP, and
c7orf59. Interestingly, no peptideswere identified corresponding
to any Rag protein, suggesting that c17orf59 only interacts with
Ragulator (Figure 1A).1446 Cell Reports 12, 1445–1455, September 1, 2015 ª2015 The AuTo confirm the mass spectrometry data, we analyzed immu-
noprecipitates of c17orf59, Ragulator, and the Rags by western
blotting. Stably expressed, epitope-tagged c17orf59 co-immu-
noprecipitated all subunits of Ragulator to levels comparable
with epitope-tagged p14 (Figure 1B). As expected, p14 inter-
acted with RagA and RagC, and c17orf59 did not co-immuno-
precipitate either RagGTPase (Figure 1B). In reciprocal immuno-
precipitations, epitope-tagged RagB co-immunoprecipitated
Ragulator subunits, but not c17orf59 (Figure 1C).
We used in vitro binding assays to test whether c17orf59 binds
directly to Ragulator, as opposed to an indirect interaction that
depends on other proteins or components of the cell. In these
assays, purified Ragulator bound c17orf59 (Figure 1D). Purified
Rags failed to interact with purified c17orf59, even when Ragu-
lator was present (Figure 1D). This confirms that c17orf59 likely
interacts directly with members of Ragulator and that the Rags
do not interact with c17orf59.
c17orf59 Localizes to the Lysosome along with
Ragulator
Ragulator localizes to lysosomes and late endosomes by virtue
of lipid modifications and targeting sequences on the N terminus
of p18 (Sancak et al., 2010, Nada et al., 2009). Consistent with its
interaction with Ragulator, hemagglutinin (HA)-tagged c17orf59
co-localizes with the lysosomal marker LAMP2 (Figure 2A),
indicating its presence at lysosomes. To determine the extent
of co-localization between c17orf59 and Ragulator, we re-ex-
pressed the cDNA for p18 in p18 null mouse embryonic fibro-
blasts (MEFs) and examined the localization of c17orf59 and
p18. Cells expressing HA-tagged c17orf59 display a highly
significant co-localization with p18 (Figures 2B, S1A, and S1B).
c17orf59 also co-localizes with another Ragulator subunit,
LAMTOR4, in a p18-dependent manner (Figure S1C), further
supporting the existence of a c17orf59-Ragulator interaction.
The subcellular localization of c17orf59 was unaffected by
the presence or absence of amino acids or insulin (Figures 2C
and 2D).
c17orf59 Loss Does Not Alter mTORC1 Activity in
Response to Amino Acids or Insulin
To examine the effects of loss of c17orf59 on mTORC1 activa-
tion, we generated c17orf59 null HEK293E and HeLa cells using
the single guide RNA (sgRNA)/Cas9 system and reconstituted
c17orf59 with expression of its cDNA driven by the c17orf59 pro-
moter. The c17orf59 null cells showed no signaling defects in
response to amino acid or serum starvation and re-stimulation,
as compared to non-targeting sgRNA or c17orf59 null cells re-
constituted with c17orf59 (Figures 3A, 3B, S2A, and S2B),
even when intermediate doses of either amino acids or insulin
were added back to cells (Figures S2C and S2D). In addition,
c17orf59 null cells had no alterations in mTORC1 signaling in
response to cholesterol deprivation, the only known stimulus
that alters c17orf59 expression (Bartz et al., 2009) (Figure S2E).
Despite its interaction with Ragulator, loss of c17orf59 does
not cause alterations in mTORC1 activation by amino acids
or insulin. This lack of signaling phenotype was consistent
across multiple clones of c17orf59 null cells using multiple
guides in both HEK293E and HeLa cells, as well as using smallthors
Figure 1. c17orf59 Is a Ragulator-Interacting Protein
(A) c17orf59 binds Ragulator. Mass spectrometric analysis of anti-FLAG-immunoprecipitates from HEK293T cells stably expressing FLAG-tagged HBXIP, a
Ragulator subunit, or c17orf59. Data are presented as average unique peptide counts from two independent immunoprecipitations of HBXIP or c17orf59.
(B) Recombinant c17orf59 co-immunoprecipitates Ragulator, but not the Rag GTPases. Stably expressed Ragulator subunit p14, c17orf59, or a control protein
(Metap2) was immunoprecipitated from HEK293T. Immunoprecipitates and whole-cell lysates were analyzed by immunoblotting for the indicated proteins.
(C) Recombinant Rag GTPases co-immunoprecipitate Ragulator, but not c17orf59. Anti-FLAG immunoprecipitates and whole-cell lysates from HEK293T cells
transiently expressing the indicated FLAG-tagged cDNA were analyzed by immunoblotting for the indicated proteins.
(D) Ragulator, but not the Rag GTPases, binds c17orf59 in in vitro assays. Recombinant, HA-GST-tagged Ragulator, Rag dimer, or Rap2a (a control protein) was
incubated with 20 pmol purified, FLAG-tagged c17orf59. In lane 5, HA-GST-tagged Rag dimer was incubated with 20 pmol FLAG-tagged Ragulator in addition to
20 pmol FLAG-tagged c17orf59. Precipitates from glutathione affinity resin were immunoblotted for the indicated epitope tags. GST-Ragulator was expressed as
HA-GST-p14, HA-MP1, -HBXIP, -c7orf59, and p18-FLAG. FLAG-Ragulator was expressed as p18-FLAG, HA-p14, -MP1, -HBXIP, and -c7orf59.hairpin RNA (shRNA)-mediated knockdown of c17orf59 (data
not shown), so we are confident that the results are not the prod-
uct of re-wiring in the single cell clones that became the c17orf59
null cells. Based on these results, we tested the effects of
c17orf59 overexpression on Ragulator function and mTORC1
activity.
c17orf59 Disrupts the Rag-Ragulator Interaction in
Cells and In Vitro
The interaction between c17orf59 and Ragulator, but not the
Rags, implies that there is a subset of the cellular pool of Ragu-Cell Relator that does not interact with the Rags. As some of this pool
interacts with c17orf59, it is possible that increasing the amount
of the c17orf59-Ragulator complex could lead to the loss
of the Rag-Ragulator interaction by titrating away Ragulator
from the Rags. We tested this hypothesis by overexpressing
c17orf59 transiently in cells expressing either FLAG-tagged
p14 or RagA.
As expected, Ragulator subunits p18 and p14 both co-immu-
noprecipitated with purified FLAG-tagged RagA when a control
protein (Methionine aminopeptidase 2, Metap2) was overex-
pressed. As expected, Raptor, the defining subunit of mTORC1,ports 12, 1445–1455, September 1, 2015 ª2015 The Authors 1447
Figure 2. c17orf59 Localizes to Lysosomes with Ragulator
(A) Recombinant c17orf59 localizes to lysosomes. p53 null MEFs were transfected with the HA-c17orf59 cDNA, immunostained with antibodies against LAMP1
(pseudocolored green) and the HA epitope tag (red), and imaged using confocal microscopy. Insets represent selected fields that have been magnified as well as
the overlay of the fields. Scale bar represents 10 mm.
(B) Recombinant c17orf59 co-localizes with p18. p18 null MEFswere transfectedwith the HA-c17orf59 and FLAG-p18 cDNA and processed and imaged as in (A),
with p18 pseudocolored red and the HA epitope tag pseudocolored green. Insets represent selected fields that have been magnified as well as the overlay of the
fields. Scale bar represents 10 mm.
(C) Recombinant c17orf59 co-localizes with lysosomes in an amino-acid-insensitive manner. p53 null MEFs were transfected with the HA-c17orf59 cDNA,
starved of amino acids for 60 min, and stimulated with amino acids for 10 min. Cells were processed and imaged as in (A) and with antibodies against LAMP1
(pseudocolored green) and the HA epitope tag (red). Insets represent selected fields that have been magnified as well as the overlay of the fields. Scale bar
represents 10 mm.
(D) Recombinant c17orf59 co-localizes with lysosomes in serum-insensitive manner. p53 null MEFs were transfected with the HA-c17orf59 cDNA, starved of
amino acids for 60 min, and stimulated with amino acids for 10 min. Cells were processed and imaged as in (A). Insets represent selected fields that have been
magnified as well as the overlay of the fields. Scale bar represents 10 mm.also co-immunoprecipitated with FLAG-RagA. However, over-
expression of c17orf59 disrupted the Rag-Ragulator complex
so that RagA no longer co-immunoprecipitated p18, p14, or
Raptor to the same extent, indicating a loss of binding to both
Ragulator andmTORC1 (Figure 4A). Conversely, immunoprecip-
itated Ragulator interacted with RagA and RagC, as well as
Raptor, but these interactions diminished upon c17orf59 overex-
pression (Figure 4B).
To examine if c17orf59 can alter the Rag-Ragulator interaction
in a cell-free setting, we used in vitro binding assays with puri-
fied proteins. Much like in cells, when purified c17orf59 was
pre-incubated with the glutathione S-transferase (GST)-tagged
Ragulator, there was a dose-dependent decrease in the amount
of purified Rags that bound to immobilized Ragulator (Figure 4C).
In a similar experiment using immobilized, GST-tagged RagB1448 Cell Reports 12, 1445–1455, September 1, 2015 ª2015 The Auwith RagC, increasing amounts of purified c17orf59 decreased
Ragulator binding to the Rags (Figure 4D).
Because Ragulator is required for the lysosomal localization
of the Rag GTPases, it is possible that the disruption of the
Rag-Ragulator interaction due to c17orf59 overexpression
results in a mislocalization of the Rag GTPases away from
the lysosome. To test this, we transiently expressed FLAG-
tagged c17orf59 in HEK293T cells, marking cells that were
transfected using GFP driven by an internal ribosome entry
sequence (IRES) downstream of the c17orf59 cDNA. The
amount of RagC that co-localizes with the lysosomal marker
LAMP1 decreases in cells that overexpress c17orf59, but
not FLAG-tagged GFP alone (Figure 4E, GFP-positive cells).
Importantly, overexpression of c17orf59 does not alter the
localization of Ragulator component LAMTOR4 (Figure S3A),thors
Figure 3. Loss of c17orf59 Does Not Alter
mTORC1 Signaling in Response to Amino
Acids or Insulin
(A) c17orf59 null cells do not have alterations in
amino-acid-sensitive mTORC1 activity. c17orf59
null HEK293E cells were generated by CRISPR/
Cas9 technology. Cells were starved of amino
acids for 1 hr and re-stimulated with amino acids
for 10 min. Lysates were analyzed by immuno-
blotting for the indicated proteins.
(B) c17orf59 null cells do not have alterations in
growth factor-sensitive mTORC1 activity. c17orf59
null HEK293E cells were starved of serum for 3 hr
and re-stimulated with insulin for 10 min. Lysates
were analyzed as in (A)indicating that Ragulator is still intact and present at
lysosomes.
In summary, c17orf59 disrupts the Rag-Ragulator complex in
cells as well as in vitro resulting in a reduction in the lysosomal
localization of the Rag GTPases. In vitro binding of either Rags
or c17orf59 to Ragulator implies that c17orf59 has the ability to
directly compete with the Rags for binding to Ragulator, produc-
ing a Rag- and mTORC1-free Ragulator-c17orf59 complex.
c17orf59 Overexpression Inhibits mTORC1
We hypothesized that because c17orf59 can disrupt the Rag-
Ragulator interaction and RagC localization, c17orf59 over-
expression would inhibit mTORC1 activation by amino acids.
Indeed, overexpression of c17orf59 produced a dose-depen-
dent inhibition of mTORC1 activation in response to amino
acid stimulation, to a level comparable to the inhibition produced
by dominant-negative RagBGDP expression (Figure 5A).
To confirm that overexpression of c17orf59 inhibits mTORC1
through the nutrient-sensing machinery and through the dis-
ruption of the Rag-Ragulator interaction, we examined mTOR
localization in cells that overexpress c17orf59. Using the
FLAG-c17orf59-IRES-GFP construct described above, mTOR
remained largely diffuse upon stimulation with amino acids in
c17orf59-expressing HEK293T cells (Figure 5B, GFP-positive
cells in the top panel). mTOR localizes to lysosomes in control
cells that either were not transfected or expressed FLAG-GFP
alone (Figure 5B, GFP-negative cells in the top panel or GFP-
positive cells in the bottom panel).
If the c17orf59-overexpression-mediated disruption of the
Rag-Ragulator interaction represents themechanismofmTORC1
inhibition by c17orf59, overexpression of c17orf59 should inhibit
mTORC1, even in cells that express thedominant-activeRagBGTP
mutant. Under normal conditions, dominant-active RagBGTP
constitutively recruits mTORC1 to the lysosome. The interaction
between Rags and Ragulator is required to bring mTORC1 to
the lysosome; disruption of the Rag-Ragulator complex by
c17orf59wouldact in anepistatic nature to the normally activating
effect of RagBGTP. Without Rag binding to Ragulator, mTORC1
will not be recruited to the lysosome.
We overexpressed c17orf59 in cells stably expressing
RagBQ99L, the RagBGTP mutant, or a control protein, Metap2.
Overexpression of c17orf59 diminished phosphorylation of S6K1
in a dose-dependent manner in both constitutively active,Cell ReRagBGTP-expressing and control cells (Figure 5C), indicating
that c17orf59 overexpression inhibits mTORC1 signaling even in
the presence of the active Rags, likely due to the loss of lysosomal
Rag localization.
DISCUSSION
Wefind that c17orf59 is a Ragulator-interacting protein. c17orf59
interacts with Ragulator in a manner that competes with the Rag
GTPases for binding, both in cells and in vitro. Loss of the Rag-
Ragulator interaction due to c17orf59 overexpression decreases
binding between the Rags and mTORC1 as well as Ragulator
and mTORC1 and prevents both the Rags and mTORC1 from
binding to the lysosomal membrane. Concomitant to the loss
of the Ragulator-Rag-mTORC1 interactions, overexpression of
c17orf59 inhibits mTORC1 activity in response to amino acid
availability. RagAGTP expression, which normally induces consti-
tutively active amino acid signaling by maintaining mTORC1 on
the lysosome, is not sufficient to rescue the signaling defect
downstream of c17orf59 overexpression, indicating that high
levels of c17or59 prevent productive interactions among the
Rags, Ragulator, and mTORC1 in a Rag nucleotide-state-inde-
pendent manner, likely by preventing the Rags from localizing
to the lysosome.
Identifying and characterizing proteins that interact with Ragu-
lator or other components of the amino-acid-sensitive mTORC1
signaling pathway is important for understanding how eukaryotic
cells sense amino acids and other nutrients that regulate
mTORC1. Ragulator was originally described as the lysosomal
scaffold for the Rags (Sancak et al., 2010), and upon identifica-
tion of additional components of the Ragulator (HBXIP and
c7orf59), we found that the scaffold also acts as a GEF for the
Rags (Bar-Peled et al., 2012). It is likely that as more Ragula-
tor-interacting proteins are uncovered, additional ways that
Ragulator can control mTORC1 will be found; here, c17orf59
competes with the Rags to bind Ragulator.
c17orf59-mediated inhibition of the Rag-Ragulator interaction
represents an alternative mechanism of mTORC1 inhibition. Po-
tential negative regulators of the amino-acid-sensing pathway
have been reported to act directly upon the Rag GTPases or
their regulatory proteins to alter their nucleotide-bound state,
including GATOR (Bar-Peled et al., 2013; Panchaud et al.,
2013), sestrins (Parmigiani et al., 2014; Chantranupong et al.,ports 12, 1445–1455, September 1, 2015 ª2015 The Authors 1449
Figure 4. c17orf59 Disrupts the Rag-Ragulator Interaction
(A) c17orf59 overexpression decreases the amount of Ragulator and Raptor recovered with immunoprecipitated Rags. Anti-FLAG immunoprecipitates and
whole-cell lysates from HEK293T cells transfected with 100 ng of the cDNAs encoding a FLAG-RagA/HA-RagC dimer or a control protein along with 1 mg HA-
c17orf59 or a control protein were analyzed by immunoblotting for the indicated proteins.
(B) c17orf59 overexpression decreases the amount of Rag and Raptor, but not Ragulator subunits, that interact with p14. Anti-FLAG immunoprecipitates and
whole-cell lysates fromHEK293T cells transfectedwith 100 ng of the cDNAs encoding FLAG-p14 andHA-MP1 or a control protein alongwith 1 mgHA-c17orf59 or
a control protein were analyzed as in (A).
(C) Purified c17orf59 binds Ragulator in vitro and inhibits the Rag-Ragulator interaction. In vitro binding assay in which recombinant HA-GST Ragulator was pre-
incubated with increasing quantities of purified FLAG-c17orf59 and followed by an incubation with purified FLAG-RagB/HA-RagC. For all samples in which
FLAG-RagC/HA-RagB were used, 2 mg (25 pmol) of Rag protein was added (lane 2, lanes 4–9). Similarly, 2 mg of FLAG-Rap2a protein as added in each marked
(legend continued on next page)
1450 Cell Reports 12, 1445–1455, September 1, 2015 ª2015 The Authors
Figure 5. Overexpression of c17orf59 In-
hibits mTORC1
(A) Overexpression of c17orf59 inhibits mTORC1
activity in cells. HEK293T cells were transfected
with 2 ng of the cDNA for FLAG-S6K1 as well
as the increasing amounts of HA-c17orf59,
HA-RagB-54L (GDP-bound mimetic), or control
protein cDNAs. The amounts of HA-c17orf59
cDNA transfected are as follows: 500 ng (lanes
5 and 6), and 2 mg (lanes 7 and 8). FLAG immu-
noprecipitates and whole cell lysates were
analyzed by immunoblotting for the indicated
proteins.
(B) c17orf59 overexpression decreases the
amount of lysosomal mTOR. HEK293T cells
were transfected with 1 mg of the cDNA encoding
FLAG-c17orf59-IRES-GFP (top panels) or FLAG-
GFP controls (bottom panels). Cells were
starved of amino acids for 1 hr, re-stimulated
with amino acids for 10 min, immunostained
with antibodies against mTOR (pseudocolored
red) and LAMP1 (green), and imaged for
GFP (white) using confocal microscopy. GFP-
positive cells (third column) represent transfected
cells.
(C) c17orf59 inhibits mTORC1 in cells with amino-
acid-insensitive mTORC1 signaling. HEK293T
cells stably expressing the RagB Q99L mutant
(GTPase deficient; GTP bound) or a control protein
were transfected with a cDNA for FLAG-S6K1
and increasing amounts of the cDNA for HA-c17orf59 as in (A). The amounts of HA-c17orf59 cDNA transfected are as follows: 500 ng (lane 2), 1 mg (lane 3), and
2 mg (lane 4). The bar above each lane is to scale for c17orf59 cDNA added. Samples were analyzed as in (A).2014; Peng et al., 2014), leucyl-tRNA synthetase (Han et al.,
2012; Bonfils et al., 2012), and SH3BP4 (Kim et al., 2012). Inter-
estingly, the mechanism of mTORC1 inhibition by c17orf59 is
independent of the Rag nucleotide-bound state, implying that
regardless of the presence of nutrients, c17orf59 can inhibit
the Rag-mTORC1 interaction and prevent mTORC1 from being
activated by Rheb.
The disruption of the Rag-Ragulator interaction by c17orf59
also suggests the possibility for the design of a new mTORC1
inhibitor. That c17orf59 can prevent the Rags from binding to
Ragulator in vitro, as well as in cells, implies that the binding
site between the two complexes is an accessible surface that
could be the target of a small molecule or peptide. A molecule
that mimics the presence of c17orf59 could provide an
mTORC1-specific inhibitor that inhibits mTORC1 completely
without affecting mTORC2. An inhibitor of only mTORC1 would
be a useful research tool to determine the distinct functions ofsample (lane 10). The amount of FLAG-c17orf59 protein added was as follows: 1
(135 pmol, lane 8), and 10 mg (270 pmol, lane 9 and all lanes marked with a ‘‘+’’). Th
glutathione affinity resin were analyzed by immunoblotting for indicated tagged p
(D) c17orf59 decreases the amount of Ragulator bound to Rags in vitro. In vitro
purified FLAG-Ragulator and increasing amounts of purified FLAG-c17orf59. Fo
protein was added (lanes 3–7). Similarly, 2 mg FLAG-Rap2a protein as added in eac
follows: 100 ng (2.7 pmol, lane 5), 500 ng (13.5 pmol, lane 6), 1 mg (27 pmol, lane 7)
lane is to scale for c17orf59 protein added. Precipitates using glutathione affinity
(E) c17orf59 overexpression decreases the amount of lysosomal RagC. HEK293T
GFP (top panels) or FLAG-GFP controls (bottom panels). Cells were starved of a
with antibodies against RagC (pseudocolored red) and LAMP1 (green), and image
represent transfected cells.
Cell Rethe complex in cells. Currently, mTOR kinase inhibitors target
both mTORC1 and mTORC2 by virtue of the shared kinase be-
tween the two complexes (Thoreen et al., 2009; Feldman and
Shokat, 2010), and rapamycin, which was originally thought to
be mTORC1 specific, is a compromised tool to interrogate
mTORC1 activity, because it only partially inhibits mTORC1
and can inhibit mTORC2 assembly upon prolonged treatment
(Thoreen et al., 2009; Feldman et al., 2009; Sarbassov et al.,
2006). Peptides derived from c17orf59 could potentially inhibit
mTORC1; alternatively, a small molecule that binds to the
same accessible surface on the structure of Ragulator that
c17orf59 and, likely, the Rags bind to could be an effective
mTORC1 inhibitor.
The binding of c17orf59 to the Ragulator in a Rag-independent
manner and the inhibition of mTORC1 activity by c17orf59 over-
expression suggest that c17orf59 is a negative regulator of the
nutrient-sensing pathway. However, loss of c17orf59 did not00 ng (2.7 pmol, lane 5), 500 ng (13.5 pmol, lane 6), 1 mg (27 pmol, lane 7), 5 mg
e bar above each lane is to scale for c17orf59 protein added. Precipitates using
roteins.
binding assay in which purified HA-GST-RagB/HA-RagC was incubated with
r all samples in which FLAG-Ragulator was used, 1 mg (14 pmol) of Ragulator
hmarked sample (lane 3). The amount of FLAG-c17orf59 protein addedwas as
, and 2 mg (54 pmol, lane 8 and all lanes marked with a ‘‘+’’). The bar above each
resin precipitates were analyzed as in (C).
cells were transfected with 1 mg of the cDNA encoding FLAG-c17orf59-IRES-
mino acids for 1 hr, re-stimulated with amino acids for 10 min, immunostained
d for GFP (white) using confocal microscopy. GFP-positive cells (third column)
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result in detectable defects in mTORC1 signaling in response
to starvation of or re-stimulation by amino acids or insulin in
HEK293E and HeLa cell lines. c17orf59 null cells also displayed
no alterations in the inhibition of mTORC1 by cholesterol depri-
vation, the only reported regulator of c17orf59 expression. It is
possible that other conditions may inhibit mTORC1 in a manner
that depends on either an increase in c17orf59 expression or
promotes c17orf59 binding to Ragulator.
c17orf59 is present in and binds to Ragulator in the cell lines
used in this work; however, it is possible that there are cell types
that express c17orf59 at a higher level, which would allow for
greater levels of binding and inhibition of mTORC1 and might
manifest stronger response to c17orf59 loss or perturbation.
It is also possible that c17orf59 is not a negative regulator of
the mTORC1 pathway, but rather that the c17orf59-Ragulator
complex has mTORC1-independent functions. c17orf59 could
have a role in a different, unidentified pathway that also
utilizes Ragulator. If this were the case, Ragulator would have
mTORC1-independent functions when bound to c17orf59 and
not the Rags. This would not be completely unprecedented, as
other components of the nutrient-sensing pathway serve other
functions in the cell. We have previously shown that the v-
ATPase is a Ragulator-binding complex that not only regulates
mTORC1 signaling but also functions as a major proton pump
to maintain the acidic nature of the lysosome as well as other
organelles and that the maintenance of pH may be de-coupled
from the role of the v-ATPase in mTORC1 activation (Zoncu
et al., 2011). Similarly, GATOR2, which acts is upstream of the
GAP for RagA and B (GATOR1) and is required for amino acid
signaling to mTORC1, includes Sec13 and Seh1L (Bar-Peled
et al., 2013), which serve multiple other functions in the cell.
Sec13 is a COPII component required for the generation of ves-
icles that traffic from the ER andGolgi and also participates in the
nuclear pore complex (Devos et al., 2004; Gu¨rkan et al., 2006;
Brohawn et al., 2009). Seh1L is also a component of the nuclear
pore complex, where it binds directly to Sec13 (Brohawn et al.,
2009).
One potential function for the c17orf59-Ragulator complex
could be the recently described BLOC-1-related complex
(BORC), which contains c17orf59 and controls lysosomal posi-
tioning (Pu et al., 2015). It is unclear how the assembly of
BORC is regulated within the cell or if this complex regulates
mTORC1, but the authors imply that Ragulator interacts with
BORC subunits (Pu et al., 2015), which would indicate a role
for the c17orf59-Ragulator complex in lysosomal positioning
as a part of BORC. This is consistent with literature that Ragula-
tor components are important for maintaining endolysosomal
morphology and biogenesis (Teis et al., 2006; Nada et al.,
2009; Takahashi et al., 2012; Vogel et al., 2015) and consistent
with our observed alterations in lysosomal staining in cells
that overexpress c17orf59 (Figures 4E and 5B). It is possible
that Ragulator binds to c17orf59 and BORC in a Rag- and
mTORC1-independent manner to control endosome and lyso-
some morphology.
Cholesterol deprivation has been shown to cause a mild in-
crease in c17orf59 expression in the only previously reported
regulation or function of c17orf59 (Bartz et al., 2009). When we
deprived cells of cholesterol, we saw a mild upregulation of1452 Cell Reports 12, 1445–1455, September 1, 2015 ª2015 The Auc17orf59 at the protein level, in accordance with the previously
reported regulation of c17orf59, potentially by the sterol-respon-
sive element binding protein (SREBP) (Bartz et al., 2009).
It remains to be determined if c17orf59 is indeed a negative
regulator of the nutrient-sensing pathway or if it is a component
of a Ragulator-containing pathway that acts independently of
mTORC1. Regardless of the physiological role of c17orf59 in
the cell, we have uncovered an additional cellular mechanism
for mTORC1-specific inhibition, namely by altering the Rag-Ra-
gulator interaction.
EXPERIMENTAL PROCEDURES
Reagents
The following antibodies were obtained from Cell Signaling Technologies
(CST): antibodies against phospho-T389-S6K (#9206 and #9205), S6K1
(9202 and 2708), mTOR (#293), c7orf59/LAMTOR4 (#12284 for blotting;
#13140 for immunofluorescence), p18 (#8975), MP1 (#8168), p14 (#8145),
HBXIP (#14633), RagA (#4357), RagC (#3360), FLAG epitope (2368), and HA
epitope (#2367 and #3724). Antibodies against Raptor (Millipore #09-217),
FLAG (Sigma #F1804), LAMP1 (Developmental Studies Hybridoma Bank at
the University of Iowa #1D4B), LAMP2 (Santa Cruz Biotechnology #18822),
and actin (Sigma #A5441) were obtained elsewhere. The antibody to
c17orf59 was a generous gift from Jianxin Xie at CST.
Inactivated fetal bovine serum (IFS), RPMI, and DMEM were obtained from
US Biologicals. Amino acids for re-stimulation experiments were purchased
from Sigma and dissolved in water to a concentration of 103 compared to
the RPMI amino acid concentrations, as described previously (Sancak et al.,
2008).
Cell Lysis and Immunoprecipitation
Cells were washed once with ice-cold PBS and lysed with CHAPS lysis buffer
(0.3% CHAPS [Sigma #C3023], 10 mM beta-glycerol phosphate [Sigma
#G9422], 10 mM sodium pyrophosphate [Sigma #221368], 40 mM HEPES
[pH 7.4], and 2.5 mM MgCl2) with one tablet of EDTA-free protease inhibitor
(Roche #11 873 580 001) per 25 ml. Lysates were cleared by centrifugation
at 13,000 rpm in a table-top microcentrifuge for 10 min. For anti-FLAG immu-
noprecipitations, cleared lysates were normalized for protein content by Brad-
ford assay (Bio-Rad #500-0006) and incubated for 1.5–3 hr with 30 ml of a 50%
slurry of FLAG-M2 affinity gel (Sigma #A2220) that had been washed three
times in lysis buffer. After incubation, beadswere washed three timeswith lysis
buffer containing 150 mMNaCl. Immunoprecipitated proteins were denatured
by the addition of 35 ml sample buffer and boiling for 5 min. In experiments us-
ing only cell lysates, without immunoprecipitation, 1% Triton X-100 (Sigma
T9284) was substituted for CHAPS in the lysis buffer.
In transfection experiments in which epitope-tagged proteins were immuno-
precipitated, 2 million HEK293T cells were seeded in 10-cm culture dishes.
24 hr later, 500 ng of each pRK5-based plasmid was transfected using X-trem-
eGENE9 (Roche #06 365 809 001) according to the manufacturer’s protocol
(FLAG-Metap2, FLAG-p14/HA-MP1, FLAG-c17orf59, and FLAG-RagB/HA-
RagC). Empty pRK5 vector was used to normalize total plasmid amount to
2 mg per 10-cm culture dish. 36 hr after transfection, cells were lysed in 1 ml
lysis buffer as described above.
For experiments in which c17orf59 was expressed with Rag or Ragulator
components, 2 million HEK293T cells were seeded in 10-cm culture dishes.
24 hr later, the following pRK5-based plasmids were transfected using X-trem-
eGENE9: 100 ng of each FLAG-Metap2, FLAG-p14 with HA-MP1, FLAG-RagB
with HA-RagC co-transfected with 1 mg of either HA-c17orf59 or HA-Metap2.
36 hr after transfection, cells were lysed in CHAPS lysis buffer as described
above.
For experiments where cells were starved and re-stimulated with amino
acids or insulin, 400,000 HEK293E cells were seeded in six-well plates coated
with fibronectin (Millipore #341635). 48 hr later, cells were washed once with
PBS or starvation media and incubated in RPMI lacking all amino acids (US Bi-
ologicals #R9010) supplemented with 5% dialyzed IFS for 1 hr or in DMEMthors
without serum for 3 hr and stimulated with amino acids or insulin (100 ng/ml;
Sigma # I2643) for 10 min. Cells were lysed as described above in 130 ml Triton
lysis buffer. Alternatively, 500,000 HeLa cells were seeded in six-well plates
and starved, re-stimulated, and lysed as described above after culturing
overnight.
For dialysis, 100 ml IFS was dialyzed in SnakeSkin Dialysis Tubing with a
3.5-kDa cutoff (Thermo #PI88244) against approximately 3 l PBS at 4C for
48 hr, replacing with fresh PBS after 24 hr.
c17orf59 Overexpression in Signaling Experiments
In experiments where mTORC1 activity was assessed upon overexpression of
c17orf59, FLAG-S6K1 co-expression and immunoprecipitation was used as
described previously (Bar-Peled et al., 2012). Briefly, 2 million HEK293T cells
were seeded in 10-cm culture dishes. 24 hr later, 2 mg of the cDNA for a control
protein, HA-Metap2, 200 ng HA-RagB-T54N (RagBGDP), or between 500 ng
and 2 mg of the cDNA for HA-c17orf59 was co-transfected into HEK293T cells
with 2 ng of the cDNA for FLAG-S6K1. Empty pRK5 vector was used to
normalize total plasmid amount to 2 mg per 10-cm plate. 36 hr post-transfec-
tion, cells were starved of amino acids, stimulated with amino acids, and lysed,
and FLAG-S6K1 was immunoprecipitated as described above.
Mass Spectrometry
Immunoprecipitates from nearly confluent 15-cm culture dishes containing
HEK293T cells stably expressing FLAG-Metap2, FLAG-HBXIP, or FLAG-
c17orf59 were prepared using CHAPS lysis as described above, except 50 ml
of FLAG-M2 affinity gel was used for immunoprecipitations and beads were
washed six times in lysis buffer containing 150 mM NaCl. Bound proteins were
eluted fromtheFLAG-M2affinitygelby incubation in50ml 1mg/mlFLAG-peptide
(sequence DYKDDDK) for 45 min on ice and denatured by addition of loading
buffer and boiling for 5 min. Samples were resolved on 4%–12% NuPage
gels (Life Technologies) and stained with SimplyBlue SafeStain (Life Technolo-
gies LC6065). Each lane was cut into ten pieces and digested in trypsin
overnight. Resulting digests were analyzed at the Whitehead Institute Prote-
omics core using a Thermo Fisher LTQ with Waters NanoAcuity UPLC mass
spectrometer. Data were analyzed using Scaffold Free Viewer (Proteome
Software).
In Vitro Binding
Purification of recombinant proteins and in vitro binding assays using GST-
tagged Rag GTPases or Ragulator were done as described previously
(Bar-Peled et al., 2012). Briefly, 4 million HEK293T cells were seeded in
15-cm culture dishes. 48 hr after seeding, cells were transfected with
cDNA for the following genes using PEI (Polysciences #23966; 3 ml PEI at
1 mg/ml per mg DNA): for HA-GST-Ragulator: 4 mg HA-GST-p14, 8 mg HA-
MP1, 8 mg p18G2A-FLAG (a lipidation-defective mutant), 8 mg HA-HBXIP,
and 8 mg HA-c7orf59; for FLAG-Ragulator: 4 mg p18G2A-FLAG, 8 mg HA-
MP1, 8 mg HA-p14, 8 mg HA-HBXIP, and 8 mg c7orf59; for HA-GST-Rag
GTPases: 8 mg HA-GST-RagB, 16 mg HA-RagC; for FLAG-Rag GTPases:
8 mg FLAG-RagB, 16 mg HA-RagC; for individual proteins: 10 mg FLAG-
c17orf59; 10 mg FLAG-Rap2a; 10 mg HA-GST-Rap2a.
36 hr after transfection, cells were lysed as described above, using 750 ml
Triton lysis buffer per dish. After clearing the lysates, 50 ml of a 50% slurry of
FLAG-M2 affinity resin in lysis buffer or 200 ml of a 50% slurry of immobilized
glutathione affinity resin (Thermo #15160) in lysis buffer was added to lysates
expressing FLAG- or GST-tagged proteins, respectively. Recombinant pro-
teins were incubated with affinity resin for 2 hr at 4C with rotation. Each sam-
ple was washed once in lysis buffer, five times in wash buffer (0.3% CHAPS,
2.5 mMMgCl2, 40 mM HEPES, and 500 mM NaCl), and three times in binding
buffer (0.3% CHAPS, 2.5 mM MgCl2, and 40 mM HEPES). GST-tagged sam-
ples were re-suspended in 160 ml binding buffer, and FLAG-tagged samples
were eluted in 50 ml FLAG-peptide in binding buffer. When necessary, eluates
were concentrated using centrifugal filters with a 10-kDa cutoff (Millipore
#UFC501024).
For the initial binding reactions, 20 ml of glutathione affinity resin containing
immobilized HA-GST-tagged proteins was incubated in binding buffer supple-
mented with 2 mM DTT and 1 mg/mL BSA (New England Biolabs [NEB]
#B9000) with 745 ng (20 pmol) FLAG-c17orf59 or 1.5 mg (20 pmol) FLAG-Ra-Cell Regulator to a final volume of 50 ml for 90 min on ice. To terminate binding assays,
samples were washed three times with 1 ml of ice-cold binding buffer supple-
mented with 150 mM NaCl followed by the addition of 50 ml sample buffer.
Binding assays in which increasing amounts of c17orf59 were added to
GST-tagged Ragulator or Rag GTPases were done as described above,
except that FLAG-c17orf59 was incubated with FLAG-Ragulator for 30 min
prior to the incubation with other proteins on ice. For experiments where
FLAG-c17orf59 was added to GST-Ragulator, 100 ng to 10 mg (2.7–270
pmol) was incubated with Ragulator and 2 mg (25 pmol) Flag Rags were added
to the reaction for 90 min. For experiments where FLAG-c17orf59 was added
to GST-Rags, 100 ng to 2 mg (2.7–54 pmol) was incubated with 1 mg (14 pmol)
FLAG-Ragulator for 30 min prior to addition to GST-Rag GTPases.
Immunofluorescence
1.5 million p53 null MEFs were transfected with 20 ng HA-c17orf59 and 1 mg
empty pRK5 using the MEF Nucleofector kit 1 (Lonza #VPD-1004) using a nu-
cleofector (Lonza) and seeded onto fibronectin-coated glass coverslips. Two
wells of a six-well culture dish were seeded per 1.5 million MEFs transfected.
The following day, cells were either left untreated or starved and re-stimulated
of amino acids or insulin as described above. Slides were fixed and processed
as described previously (Zoncu et al., 2011). Briefly, the slideswere rinsed once
with PBS and fixed using 4%paraformaldehyde in PBS for 15min. Slides were
washed twice with PBS and permeabilized with 0.05% Triton X-100 in
PBS for 15 min. Slides were washed three times in PBS and incubated with
primary antibody in 5% normal donkey serum (Jackson #017-000-121) for
1 hr at room temperature (1:300 for anti-LAMP1 antibody and 1:150 for anti-
HA antibody), washed three times with PBS, incubated with secondary anti-
bodies produced in donkey (diluted 1:500 in 5% normal donkey serum) for
45 min at room temperature in the dark, and washed three times with PBS.
Slides were mounted on glass coverslips using ProLong Diamond Antifade
Mountant (Molecular Probes #P36966) and imaged on a spinning disk confocal
system (Perkin Elmer).
p18/ MEFs were transfected, treated, and fixed as above. Samples were
washed three times in PBS and blocked for 1 hr in 5% normal donkey serum in
PBS containing 0.3% Triton. Samples were incubated in primary antibodies
diluted in 1% BSA in PBS containing 0.3% Triton overnight in a humidified
chamber at 4C. Primary antibodies usedwere as follows: anti-LAMP1 (diluted
1:200), anti-HA (diluted 1:100), p18 (diluted 1:100), and LAMTOR4 (diluted
1:800). The next day, samples were washed with PBS three times and incu-
bated for 1–2 hr at room temperature with Alexa-Fluor-conjugated secondary
antibodies (Molecular Probes, diluted 1:500). Samples were then washed two
times with PBS and incubated with Hoechst 33342 (Molecular Probes H3570,
1:10,000) in PBS for 15 s and washed twice in PBS. Coverslips were mounted
on glass slides with Vectashield Mounting Media and cured overnight at room
temperature and then imaged as described above.
Alternatively, HEK293T cells were transfected with 1 mg FLAG-c17orf59-
IRES-GFP or 1 mg FLAG-GFP with 1 mg empty pRK5 in 10-cm culture plates
as described above for signaling experiments. 24 hr after transfection,
300,000 cells were seeded per well on fibronectin-coated coverslips in six-
well plates. The following day, cells were processed as described above and
stained using anti-LAMP2 antibody at 1:400, anti-mTOR at 1:200, anti-RagC
at 1:100, or anti-LAMTOR4 at 1:800.
Images are maximum projections of 0.5-mm z stacks. For MEF images, five
slices were used; ten slices were used for HEK293T images. Pearson’s corre-
lation was calculated for the p18-c17orf59 quantitation using ImageJ Coloc 2
plugin and analyzed using a Students two-tailed t test.
Generation of CRISPR/Cas9-Knockout Cells
To generate c17orf59 null cells, guide RNAs were cloned into the pLenti-
CRISPR vector (Addgene) that was cut with BbsI (NEB #R0539). Guide
RNAs were generated by annealing the following pairs of oligonucleotides
and ligated into pLentiCRISPR:
Guide 1 forward (fwd): 50-caccGGGGCGGCCCGGGCCCGAGA-30
Guide 1 reverse (rev): 50-aaacTCTCGGGCCCGGGCCGCCCC-30
Guide 2 fwd: 50-caccgCAAAGTGGGTAAGGTCGCCG-30
Guide 2 rev: 50-aaacCGGCGACCTTACCCACTTTGc-30ports 12, 1445–1455, September 1, 2015 ª2015 The Authors 1453
One million HEK293E or 500,000 HeLa cells were seeded in 10-cm culture
dishes. 24 hr later, cells were transfected with 500 ng guide RNA plasmid
with X-tremeGENE9. The following day, transfected cells were selected using
puromycin. 48 hr after puromycin selection started, cells were re-transfected
with guide RNA plasmid and allowed to grow to near confluence. 90%
confluent dishes were trypsinized and single-cell sorted with a flow cytometer
into the wells of a 96-well plate containing 150 ml DMEM supplemented with
30% IFS. Cells were grown until visible colonies were present, and the resul-
tant colonies were trypsinized and expanded. Clones were validated for loss
of the c17orf59 via immunoblotting.
Cholesterol Depletion
Cells were depleted of cholesterol using a protocol modified from that
described previously (Bartz et al., 2009). Briefly, 3 million HeLa cells were
seeded in 10-cm culture dishes. The following day, cells were washed
twice in PBS and media was changed to either full DMEM with 10% IFS
or DMEM containing 0.5% lipid-depleted serum (LDS; Intracel #RP-056).
Twenty-four hours later, cells were incubated with DMEM with 10% IFS,
DMEM with 0.5% LDS, or 2% 2-hydroxypropyl-b-cyclodextrin in DMEM
with 0.5% LDS for 5 hr. Cells were lysed in 1 ml Triton lysis buffer as
described above.
c17orf59 cDNA Cloning
c17orf59 cDNA was PCR amplified from HEK293T cDNA using PlatinumTaq
HIFI (Life Technology) and the gene-specific primers listed below, which
have SalI and BamHI sites added at the 50 and 30 ends, respectively. The
PCR product was purified from a 1% agarose gel and digested with SalI
and BamHI restriction endonucleases (NEB #R0138 and #R0136) overnight.
The restriction product was gel purified and ligated into previously SalI-
BamHI-digested pRK5. For further subcloning, a NotI site present in the
c17orf59 cDNA was mutated using overlapping PCR with the following
primers, digested with SalI and NotI (NEB #R0189), and ligated into SalI-
NotI-digested pRK5.
To amplify c17orf59 cDNA from HEK293T, the following primers were
used:
Fwd: 50-ACGCGTCGACGATGGAGTCGTCTCGGGGGCGG-30
Rev: 50-CGCGGATCCTCACTTGCACAGGGCCTCCAA-30
To remove the internal NotI site and add SalI-NotI subcloning sites, the
following primers were used:
Fwd 1: 50-caagtcgtcgacgATGGAGTCGTCTCGGGGGC-30
SDM1 rev: 50-CGAGGAGGCTGCAGCGGGCAGC-30
SDM2 fwd: 50-GCTGCCCGCTGCAGCCTCCTCG-30
Rev2: 50-catgatgcggcccgcTCACTTGCACAGGGCCTCC-30
The 1,000 nucleotides upstream of the c17orf59 gene locus were used as its
endogenous promoter and amplified by PCR from genomic DNA from
HEK293T cells with the below primers and ligated to c17orf59 and pLEX-
TRC202 plasmid cut with XmaI and BsrGI (NEB #R0180 and #R0575) by
Gibson assembly (NEB #E5510). The ligationmaintains the XmaI site upstream
of the promoter but eliminates the BsrGI site after the gene of interest.
To amplify the c17orf59 promoter, the following primers were used:
Fwd: 50-ccggctcgagggggcccgggCTTTCCAATGTCGCTGCACCATTGCAT
TTAG-30
Rev: 50-catttccatACTGCAGGTGGGGGCCGC-30
To amplify FLAG-c17orf59, the following primers were used:
Fwd: 50-cctgcagtATGGAAATGGACTACAAGGATGAC-30
Rev: 50-gtctcgagttaggacttTCACTTGCACAGGGCCTC-30
To generate the FLAG-c17orf59-IRES-GFP construct, FLAG-c17orf59
cDNA was generated by PCR using a forward primer adding an NheI site
and Kozak sequence to the FLAG tag and the NotI-Rev2 primer described
above, purified, and digested using NheI and NotI restriction endonucleases
(NEB #R0131 and #RO189). Digested PCR produce was ligated into
pCAGGS-PSAML141F, Y115F:GlyR-IRES-GFP (Addgene #32480) that had
been digested with NheI and NotI to remove the insert.1454 Cell Reports 12, 1445–1455, September 1, 2015 ª2015 The AuthorTo amplify FLAG-c17orf59 for cloning into pCAGGS-IRES-GFP, the
following primers were used:
Fwd: 50-caagtccgtagcgccaccATGGAAATGGACTACAAGGATG-30
Rev: 50-catgatgcggcccgcTCACTTGCACAGGGCCTCC-30SUPPLEMENTAL INFORMATION
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